Matthew M. Roforth

1.0k total citations
27 papers, 740 citations indexed

About

Matthew M. Roforth is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Matthew M. Roforth has authored 27 papers receiving a total of 740 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Genetics and 5 papers in Oncology. Recurrent topics in Matthew M. Roforth's work include Bone Metabolism and Diseases (12 papers), Estrogen and related hormone effects (7 papers) and Bone health and osteoporosis research (4 papers). Matthew M. Roforth is often cited by papers focused on Bone Metabolism and Diseases (12 papers), Estrogen and related hormone effects (7 papers) and Bone health and osteoporosis research (4 papers). Matthew M. Roforth collaborates with scholars based in United States, Australia and United Kingdom. Matthew M. Roforth's co-authors include Sundeep Khosla, David G. Monroe, James M. Peterson, Louise K. McCready, Matthew T. Drake, Koji Fujita, Ulrike I. Mödder, Chalet Tan, Merry Jo Oursler and Elizabeth J. Atkinson and has published in prestigious journals such as Blood, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Matthew M. Roforth

26 papers receiving 722 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew M. Roforth United States 17 368 174 162 149 103 27 740
Rosa Artells Spain 16 555 1.5× 211 1.2× 278 1.7× 238 1.6× 75 0.7× 39 1.1k
Carmen Huesa United Kingdom 17 322 0.9× 118 0.7× 99 0.6× 151 1.0× 57 0.6× 42 896
Yoshinobu Higuchi Japan 13 592 1.6× 103 0.6× 176 1.1× 150 1.0× 110 1.1× 16 959
Deena Durant United States 17 611 1.7× 82 0.5× 208 1.3× 108 0.7× 94 0.9× 19 904
Narelle E. McGregor Australia 19 816 2.2× 189 1.1× 584 3.6× 142 1.0× 238 2.3× 36 1.2k
Omar Khalid United States 16 620 1.7× 61 0.4× 216 1.3× 204 1.4× 45 0.4× 22 930
C. Manning United States 11 531 1.4× 127 0.7× 203 1.3× 36 0.2× 132 1.3× 15 832
Adrienne Anginot France 12 248 0.7× 36 0.2× 116 0.7× 51 0.3× 195 1.9× 16 594
Jukka Vääräniemi Finland 11 452 1.2× 175 1.0× 286 1.8× 64 0.4× 108 1.0× 14 746
Sooyeon Lee Germany 11 262 0.7× 47 0.3× 120 0.7× 63 0.4× 51 0.5× 17 647

Countries citing papers authored by Matthew M. Roforth

Since Specialization
Citations

This map shows the geographic impact of Matthew M. Roforth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew M. Roforth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew M. Roforth more than expected).

Fields of papers citing papers by Matthew M. Roforth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew M. Roforth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew M. Roforth. The network helps show where Matthew M. Roforth may publish in the future.

Co-authorship network of co-authors of Matthew M. Roforth

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew M. Roforth. A scholar is included among the top collaborators of Matthew M. Roforth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew M. Roforth. Matthew M. Roforth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grannas, Karin, Robert Movérare, Matthew M. Roforth, et al.. (2024). Evaluating the Performance of Two Automated Anti-drug Antibodies Assays for Infliximab and Adalimumab Without Acid Dissociation. The AAPS Journal. 26(5). 86–86. 3 indexed citations
2.
Blommel, Joseph H., Matthew M. Roforth, Calvin R. Jerde, et al.. (2024). Evaluating User Experience and DNA Yield from Self-Collection Devices. The Journal of Applied Laboratory Medicine. 9(4). 704–715.
3.
Ewaisha, Radwa, Matthew M. Roforth, Dane Granger, et al.. (2022). Limited Correlation between SARS-CoV-2 Serologic Assays for Identification of High-Titer COVID-19 Convalescent Plasma Using FDA Thresholds. Microbiology Spectrum. 10(4). e0115422–e0115422. 4 indexed citations
4.
Taylor, Bruce, Christopher J. Klein, Matthew M. Roforth, et al.. (2019). Polyneuropathies and chronic inflammatory demyelinating polyradiculoneuropathy in multiple sclerosis. Multiple Sclerosis and Related Disorders. 30. 284–290. 9 indexed citations
5.
Martinez‐Thompson, Jennifer M., Melissa R. Snyder, Andrew McKeon, et al.. (2017). Composite ganglioside autoantibodies and immune treatment response in MMN and MADSAM. Muscle & Nerve. 57(6). 1000–1005. 10 indexed citations
6.
McKeon, Andrew, Daniel H. Lachance, Sean J. Pittock, et al.. (2016). Recoverin Antibody: Ophthalmologic & Oncologic Significance (P6.131). Neurology. 86(16_supplement). 1 indexed citations
7.
Roforth, Matthew M., Joshua N. Farr, Koji Fujita, et al.. (2015). Global transcriptional profiling using RNA sequencing and DNA methylation patterns in highly enriched mesenchymal cells from young versus elderly women. Bone. 76. 49–57. 23 indexed citations
8.
Farr, Joshua N., Matthew M. Roforth, Koji Fujita, et al.. (2015). Effects of Age and Estrogen on Skeletal Gene Expression in Humans as Assessed by RNA Sequencing. PLoS ONE. 10(9). e0138347–e0138347. 55 indexed citations
9.
Roforth, Matthew M., Elizabeth J. Atkinson, Ellis R. Levin, Sundeep Khosla, & David G. Monroe. (2014). Dissection of Estrogen Receptor Alpha Signaling Pathways in Osteoblasts Using RNA-Sequencing. PLoS ONE. 9(4). e95987–e95987. 18 indexed citations
10.
Peris, Pilar, Matthew M. Roforth, Kristy M. Nicks, et al.. (2014). Ability of Circulating Human Hematopoietic Lineage Negative Cells to Support Hematopoiesis. Journal of Cellular Biochemistry. 116(1). 58–66. 2 indexed citations
11.
Roforth, Matthew M., Sundeep Khosla, & David G. Monroe. (2013). Identification of Rorβ targets in cultured osteoblasts and in human bone. Biochemical and Biophysical Research Communications. 440(4). 768–773. 18 indexed citations
12.
Roforth, Matthew M., Koji Fujita, Salman Kirmani, et al.. (2013). Effects of age on bone mRNA levels of sclerostin and other genes relevant to bone metabolism in humans. Bone. 59. 1–6. 94 indexed citations
13.
Fujita, Koji, Matthew M. Roforth, Elizabeth J. Atkinson, et al.. (2013). Isolation and characterization of human osteoblasts from needle biopsies without in vitro culture. Osteoporosis International. 25(3). 887–895. 23 indexed citations
14.
Fujita, Koji, Matthew M. Roforth, Salman Kirmani, et al.. (2013). Effects of Estrogen on Bone mRNA Levels of Sclerostin and Other Genes Relevant to Bone Metabolism in Postmenopausal Women. The Journal of Clinical Endocrinology & Metabolism. 99(1). E81–E88. 64 indexed citations
15.
Mödder, Ulrike I., Matthew M. Roforth, Kelley A. Hoey, et al.. (2011). Effects of estrogen on osteoprogenitor cells and cytokines/bone-regulatory factors in postmenopausal women. Bone. 49(2). 202–207. 66 indexed citations
16.
Mödder, Ulrike I., Matthew M. Roforth, Kristy M. Nicks, et al.. (2011). Characterization of mesenchymal progenitor cells isolated from human bone marrow by negative selection. Bone. 50(3). 804–810. 37 indexed citations
17.
Drake, Matthew T., Bhuma Srinivasan, Ulrike I. Mödder, et al.. (2011). Effects of intermittent parathyroid hormone treatment on osteoprogenitor cells in postmenopausal women. Bone. 49(3). 349–355. 27 indexed citations
18.
Roforth, Matthew M., Gang Liu, Sundeep Khosla, & David G. Monroe. (2011). Examination of nuclear receptor expression in osteoblasts reveals rorβ as an important regulator of osteogenesis. Journal of Bone and Mineral Research. 27(4). 891–901. 32 indexed citations
19.
Roforth, Matthew M. & Chalet Tan. (2008). Combination of rapamycin and 17-allylamino-17-demethoxygeldanamycin abrogates Akt activation and potentiates mTOR blockade in breast cancer cells. Anti-Cancer Drugs. 19(7). 681–688. 29 indexed citations
20.
Taylor, Patricia A., Michael Ehrhardt, Matthew M. Roforth, et al.. (2006). Preformed antibody, not primed T cells, is the initial and major barrier to bone marrow engraftment in allosensitized recipients. Blood. 109(3). 1307–1315. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026